A. Sonntag

发表

Depression during therapy with interferon α - How long should an antidepressant treatment last? A case report

T. Pollmächer, T. Nickel, A. Sonntag, 2005 .

Depression during therapy with interferon alpha--how long should an antidepressant treatment last?

T. Pollmächer, T. Nickel, A. Sonntag, 2005, Pharmacopsychiatry.

Clinical outcome after trimipramine in patients with delusional depression - a pilot study.

P. Baumann, R. Frieboes, A. Yassouridis, 2003, Pharmacopsychiatry.

Psychiatric sequelae of listeriosis

F. Strian, M. Kellner, A. Sonntag, 1990, British Journal of Psychiatry.

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.

F. Holsboer, T. Pollmächer, E. Binder, 2008, Journal of psychiatric research.

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated.

F. Holsboer, M. Ising, A. Zobel, 2000, Journal of psychiatric research.

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.

F. Holsboer, M. Ising, M. Uhr, 2001, Journal of psychiatric research.

Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression.

F. Holsboer, M. Ising, M. Uhr, 2005, Journal of psychiatric research.

Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.

A. Steiger, F. Holsboer, S. Kasper, 2009, Journal of psychiatric research.

To what degree does the Composite International Diagnostic Interview (CIDI) correctly identify DSM‐IV disorders? Testing validity issues in a clinical sample

A. Steiger, H. Wittchen, H. Pfister, 1998 .

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects.

Florian Holsboer, Nibal Ackl, Manfred Uhr, 2003, Journal of psychiatric research.

Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.

A. Steiger, F. Holsboer, J. Guldner, 1996, Depression.

Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression

A. Steiger, F. Holsboer, J. Zihl, 2003, Journal of clinical psychopharmacology.

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease

D. Auer, M. Atiya, M. Ising, 2005, Neuroscience Letters.

Changes of Sleep Architecture, Spectral Composition of Sleep EEG, the Nocturnal Secretion of Cortisol, ACTH, GH, Prolactin, Melatonin, Ghrelin, and Leptin, and the DEX-CRH Test in Depressed Patients during Treatment with Mirtazapine

A. Steiger, A. Wichniak, M. Ising, 2006, Neuropsychopharmacology.

State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine

A. Steiger, F. Holsboer, A. Zobel, 2003, Neuropsychopharmacology.

Changes in clinical symptoms, sleep EEG and nocturnal hormone secretion during treatment with trimipramine or imipramine — a double-blind comparison in patients with major depression

A. Steiger, F. Holsboer, J. Guldner, 1993, European Neuropsychopharmacology.

Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis

G. Wiedemann, A. Sonntag, A. Möller, 1994, Acta psychiatrica Scandinavica.

Enhanced long-latency somatosensory potentials in major depressive disorder.

T. Dietl, G. Dirlich, L. Vogl, 2001, Journal of psychiatric research.

Toward a Reliable Distinction Between Patients with Mild Cognitive Impairment and Alzheimer-Type Dementia Versus Major Depression

F. Holsboer, E. Binder, A. Post, 2006, Biological Psychiatry.

Affective temperaments and residual symptoms in patients with mood and anxiety disorders.

F. Holsboer, T. Pollmächer, E. Binder, 2009 .

Long-latency somatosensory potentials in high risk probands for affective disorders.

T. Pollmächer, T. Dietl, G. Dirlich, 2004, Journal of psychiatric research.

Ziprasidone-related tardive dyskinesia.

F. Holsboer, E. Binder, M. Keck, 2004, The American journal of psychiatry.

Growth hormone-releasing hormone (GHRH)-induced effects on sleep EEG and nocturnal secretion of growth hormone, cortisol and ACTH in patients with major depression.

A. Steiger, J. Guldner, E. Friess, 1994, Journal of psychiatric research.

Paroxetine for depersonalization associated with multiple sclerosis.

A. Sonntag, Tania Kümpfel, Andreas Ströhle, 2000, The American journal of psychiatry.